Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 17 Source: Estimated
- €3.2 billion turnover
- 300 employees
-
31st Dec 16 Source: Estimated
- €188.1 million turnover
- 500 employees
- 3 more years available »
Ranking
By Turnover
(€3.2 billion)- 31st in Top Companies
- 7th in Health
- 6th in Pharma
By Employees
(300)- 463rd in Top Companies
- 68th in Health
- 47th in Pharma
- 300
- €3.2 billion
Employees
- Julie O'Neill Senior vice president